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Colon cancer is the third-deadliest cancer in the United States. Better understanding the 
cancer microenvironment/niches is crucial to the development of successful therapeutic 
targets. 
 
An RNAi screening using enterocyte specific driver was performed in Drosophila 
melanogaster intestine to search for niches regulating the intestine stem cell 
homeostasis. A small GTPase, Rab11 caused strong intestine stem cell (ISC) 
proliferation and tissue hyperplasia upon knockdown, due to increased production of 
inflammatory cytokines and growth factors. Increased inflammatory cytokines and 
proliferation were also observed in mouse Rab11a knockout (KO) intestine, indicating 
Rab11 regulatory role in the inflammation-induced hyperplasia is evolutionarily 
conserved and may also apply to human.  
 
We hypothesized that Rab11 is required to maintain cytokines in an appropriate state 
and its expression is down regulated in cancers. We investigated dextran sulfate sodium 
and chemical induced mouse colon cancer. Rab11 was largely reduced/absent in cancer 
tissues whereas well present in the normal tissue. We also investigated the correlation of 
Rab11 level and human cancer progression by immunofluorescence staining, and found 
that close to 50% and 40% of the cases studied had reduced Rab11 level by 20% and 
30%, respectively. The greater the reduction is, the higher chance it is associated with 
more progressed cancer. Rab11, therefore, functions to suppress cancer progression 
and can be potentially developed towards a better diagnosis and treatment target for 
colon cancer. We will screen FDA approved drugs for ISC proliferation regulation, using 
a fly intestine tumor model established by expressing a human activated RAFGOFgene 
and a luciferase gene in the fly gut precursor cells. Selected drugs will be applied to test 
the Rab11 induced hyperplasia in fly, and further validated by mouse and human 
organoids derived from Rab11 KO mouse or human colon cancer tissues.  
 
 
 
 
